Search Results 41-50 of 16773 for Huntington's+disease

  1. Movement disorders - Doctors and departments - Mayo Clinic

    Displaying 61-2 out of 2 doctors available. Last Name Initial: S ...

  2. Mitochondrial Dynamics In Health and Disease - Mitochondrial Neurobiology and Therapeutics Laboratory - Mayo Clinic Research

    Diseases and conditions that could benefit include Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, metabolic disorders and ...

  3. Heart disease - Doctors and departments - Mayo Clinic

    Learn about symptoms, causes and treatment of cardiovascular disease, a term describing a wide range of conditions that can affect the heart.

  4. Clinical trials - Oncology (Medical)

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...

  5. Chronic kidney disease - Doctors and departments - Mayo Clinic

    Learn about kidney failure symptoms, tests, diagnosis and treatment options, including medication, dialysis and kidney transplant.

  6. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...

  7. Stevens-Johnson syndrome - Symptoms & causes - Mayo Clinic

    Learn more about the causes of this rare disorder of the skin and mucous membranes, its early signs, and whether it's preventable.

  8. Hematology - Clinical trials

    Rochester, Minn. This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) ...

  9. Comparative Gene Expression Studies in AD and Other Conditions - Genetics of Alzheimer's Disease and Endophenotypes Laboratory - Mayo Clinic Research

    Ertekin-Taner's laboratory within the umbrella of the Accelerating Medicines Partnership — Alzheimer's Disease (AMP-AD) consortium. In this project ...

  10. Clinical trials - Oncology (Medical)

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...